Verona Pharma PLC ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $5,624 | $0 | $0 | $940 |
Gross Profit | 5,081 | -270 | -262 | 730 |
EBITDA | -34,526 | -53,243 | -23,191 | -14,003 |
EBIT | -34,795 | -53,514 | -23,454 | -14,211 |
Net Income | -42,962 | -70,914 | -25,779 | -14,254 |
Net Change In Cash | 5,624 | 0 | 0 | 940 |
Free Cash Flow | -62,655 | -16,784 | -13,982 | -10,420 |
Cash | 336,040 | 404,598 | 254,882 | 271,772 |
Basic Shares | 81,493 | 81,027 | 80,712 | 80,267 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $458 | $458 | $40,000 | $2 |
Gross Profit | -679 | 112 | 40,000 | -627 |
EBITDA | -52,467 | -67,291 | -42,189 | -47,814 |
EBIT | -53,147 | -67,927 | -42,818 | -48,442 |
Net Income | -54,369 | -68,701 | -55,569 | -65,146 |
Net Change In Cash | 458 | 458 | 40,000 | 2 |
Free Cash Flow | -50,222 | -59,891 | -33,266 | -45,158 |
Cash | 271,772 | 227,827 | 148,380 | 187,986 |
Basic Shares | 79,267 | 66,133 | 59,148 | 32,866 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.56 |
2024-06-30 | -$0.88 |
2024-03-31 | -$0.32 |
2023-12-31 | -$0.18 |
